Adverse effects of extracorporeal carbon dioxide removal (ECCO2R) for acute respiratory failure: a systematic review protocol

Research output: Contribution to journalArticle

Standard

Harvard

APA

Vancouver

Author

Bibtex

@article{df996609950f422eb5053897252989d2,
title = "Adverse effects of extracorporeal carbon dioxide removal (ECCO2R) for acute respiratory failure: a systematic review protocol",
abstract = "BackgroundThe extracorporeal membrane carbon dioxide removal (ECCO2R) system is primarily designed for the purpose of removing CO2 from the body for patients with potentially reversible severe acute hypercapnic respiratory failure or being considered for lung transplantation. Systematic reviews have focused on the effectiveness of ECCO2R. To the author’s best knowledge, this is the first systematic review to focus on the adverse effects of this procedure.MethodsWe will conduct a systematic review of procedure-related adverse effects of ECCO2R systems. A high sensitivity search strategy will be employed in Cochrane Library, MEDLINE, EMBASE, Web of Science and product regulatory databases and ongoing trial registers to identify citations. Reference lists of relevant studies and grey literature will also be searched. Screening of the results will be performed by two reviewers independently using pre-defined inclusion and exclusion criteria. Clinical trials and observational studies will be included. Data will be extracted using a purposefully developed extraction form. Appropriateness for statistical pooling of the results will be determined and carried out if heterogeneity is low to moderate. The GRADE framework will be employed to grade the overall quality of the evidence.DiscussionIn the UK, the current access to the use of ECCO2R is possible only with special arrangements for clinical governance, consent and for audit or research. Current evidence on ECCO2R suggests that there are a number of well-recognised complications which vary greatly across studies. This systematic review will consolidate the existing knowledge on adverse effects resulting from the use of ECCO2R.Systematic review registrationPROSPERO CRD42015023503.",
keywords = "Extracorporeal membrane carbon dioxide removal, ECCO2R, Adverse effects, Hypercapnic respiratory failure, Lung transplantation",
author = "Zulian Liu and Rui Duarte and Susan Bayliss and George Bramley and Carole Cummins",
year = "2016",
month = "6",
day = "7",
doi = "10.1186/s13643-016-0270-0",
language = "English",
volume = "5",
journal = "Systematic Reviews",
issn = "2046-4053",
publisher = "BioMed Central Ltd",

}

RIS

TY - JOUR

T1 - Adverse effects of extracorporeal carbon dioxide removal (ECCO2R) for acute respiratory failure: a systematic review protocol

AU - Liu, Zulian

AU - Duarte, Rui

AU - Bayliss, Susan

AU - Bramley, George

AU - Cummins, Carole

PY - 2016/6/7

Y1 - 2016/6/7

N2 - BackgroundThe extracorporeal membrane carbon dioxide removal (ECCO2R) system is primarily designed for the purpose of removing CO2 from the body for patients with potentially reversible severe acute hypercapnic respiratory failure or being considered for lung transplantation. Systematic reviews have focused on the effectiveness of ECCO2R. To the author’s best knowledge, this is the first systematic review to focus on the adverse effects of this procedure.MethodsWe will conduct a systematic review of procedure-related adverse effects of ECCO2R systems. A high sensitivity search strategy will be employed in Cochrane Library, MEDLINE, EMBASE, Web of Science and product regulatory databases and ongoing trial registers to identify citations. Reference lists of relevant studies and grey literature will also be searched. Screening of the results will be performed by two reviewers independently using pre-defined inclusion and exclusion criteria. Clinical trials and observational studies will be included. Data will be extracted using a purposefully developed extraction form. Appropriateness for statistical pooling of the results will be determined and carried out if heterogeneity is low to moderate. The GRADE framework will be employed to grade the overall quality of the evidence.DiscussionIn the UK, the current access to the use of ECCO2R is possible only with special arrangements for clinical governance, consent and for audit or research. Current evidence on ECCO2R suggests that there are a number of well-recognised complications which vary greatly across studies. This systematic review will consolidate the existing knowledge on adverse effects resulting from the use of ECCO2R.Systematic review registrationPROSPERO CRD42015023503.

AB - BackgroundThe extracorporeal membrane carbon dioxide removal (ECCO2R) system is primarily designed for the purpose of removing CO2 from the body for patients with potentially reversible severe acute hypercapnic respiratory failure or being considered for lung transplantation. Systematic reviews have focused on the effectiveness of ECCO2R. To the author’s best knowledge, this is the first systematic review to focus on the adverse effects of this procedure.MethodsWe will conduct a systematic review of procedure-related adverse effects of ECCO2R systems. A high sensitivity search strategy will be employed in Cochrane Library, MEDLINE, EMBASE, Web of Science and product regulatory databases and ongoing trial registers to identify citations. Reference lists of relevant studies and grey literature will also be searched. Screening of the results will be performed by two reviewers independently using pre-defined inclusion and exclusion criteria. Clinical trials and observational studies will be included. Data will be extracted using a purposefully developed extraction form. Appropriateness for statistical pooling of the results will be determined and carried out if heterogeneity is low to moderate. The GRADE framework will be employed to grade the overall quality of the evidence.DiscussionIn the UK, the current access to the use of ECCO2R is possible only with special arrangements for clinical governance, consent and for audit or research. Current evidence on ECCO2R suggests that there are a number of well-recognised complications which vary greatly across studies. This systematic review will consolidate the existing knowledge on adverse effects resulting from the use of ECCO2R.Systematic review registrationPROSPERO CRD42015023503.

KW - Extracorporeal membrane carbon dioxide removal

KW - ECCO2R

KW - Adverse effects

KW - Hypercapnic respiratory failure

KW - Lung transplantation

U2 - 10.1186/s13643-016-0270-0

DO - 10.1186/s13643-016-0270-0

M3 - Article

VL - 5

JO - Systematic Reviews

JF - Systematic Reviews

SN - 2046-4053

M1 - 98

ER -